Cholic Acid for Hepatic Steatosis in Lipodystrophy

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Hepatic Steatosis
Interventions
DRUG

Cholic Acid

Capsules of active Cholic Acid or matching placebo, total dose is 15 mg/kg per day, maximum dose of 1500 mg per day, taken PO, BID.

Trial Locations (1)

75390-9052

University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors
collaborator

FDA Office of Orphan Products Development

FED

lead

University of Texas Southwestern Medical Center

OTHER

NCT00457639 - Cholic Acid for Hepatic Steatosis in Lipodystrophy | Biotech Hunter | Biotech Hunter